Skip to main content

Diabetes: Appropriate Treatment of Hypertension

CBE ID
0546
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Spring 2014
Is Under Review
No
1.3 Measure Description

The percentage of patients who were dispensed a medication for diabetes and hypertension that are receiving an angiotensin-converting -enzyme-inhibitor (ACEI) or angiotensin receptor blocker (ARB) or direct renin inhibitor (DRI) renin-angiotensin-antagonist medication.

    • 1.14 Numerator

      The number of patients who receive an ACEI or ARB or DRI or ACEI/ARB/DRI Combination during the measurement year.

    • 1.15 Denominator

      Patients who were dispensed at least one prescription for an oral hypoglycemic agent, insulin, incretion mimetics, and at least one prescription for an antihypertensive agent during the measurement year.

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Endocrine Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off